Stock CONTEXT THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Context Therapeutics Inc. Nasdaq

Equities

US21077P1084

Market Closed - Nasdaq
Other stock markets
 21:00:00 16/07/2024 BST 		5-day change 1st Jan Change
2.19 USD -0.45% Intraday chart for Context Therapeutics Inc. +12.89% +93.81%
05-08 Context Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-06 Context Therapeutics Inc. announced that it has received $99.992767 million in funding from Ally Bridge Group, Avidity Partners, LLC, Blue Owl Healthcare Opportunities, Deep Track Capital, LP, Driehaus Capital Management LLC, Great Point Partners, LLC CI

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Context Therapeutics Inc. Announces Management Changes
CI
Context Therapeutics Inc. Appoints Jennifer Minai-Azary as Chief Legal Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. Stock
  5. News Context Therapeutics Inc.
  6. Insiders